SUPER BUGS Act of 2023

Hozzl · 2023-12-15T15:55:08Z

Explore the details of House Bill 1305 SUPER BUGS Act of 2023 currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on International Affairs. Stay informed on legislative developments.

12/15/2023, 3:55 PM

Summary of Bill HR 1305

The SUPER BUGS Act of 2023, also known as Bill 118 hr 1305, is a piece of legislation currently being considered by the US Congress. The purpose of this bill is to address the growing threat of antibiotic-resistant bacteria, also known as superbugs, by promoting the development of new antibiotics and improving the stewardship of existing antibiotics.

The SUPER BUGS Act includes several key provisions. First, it establishes a grant program to support research and development of new antibiotics, as well as incentives for pharmaceutical companies to invest in this critical area. Additionally, the bill aims to improve surveillance and monitoring of antibiotic resistance, as well as promote the appropriate use of antibiotics in healthcare settings.

Furthermore, the SUPER BUGS Act includes measures to enhance coordination and collaboration among government agencies, healthcare providers, and researchers in the fight against superbugs. This includes the establishment of a task force to develop a national strategy for combating antibiotic resistance. Overall, the SUPER BUGS Act of 2023 represents a bipartisan effort to address a pressing public health issue. By investing in research, promoting responsible antibiotic use, and fostering collaboration, this legislation aims to protect the effectiveness of antibiotics and safeguard public health for future generations.

Congressional Summary of HR 1305

Saving Us from Pandemic Era Resistance by Building a Unified Global Strategy Act of 2023 or the SUPER BUGS Act of 2023

This bill requires the Department of Health and Human Services (HHS) to seek to enter into arrangements with foreign countries, multilateral organizations, and other appropriate entities to facilitate the development and commercialization of qualified pandemic or epidemic products, which include drugs, biological products, and medical devices. HHS shall report to Congress a strategy for achieving this goal.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill HR 1305

Bill HR 1305 is currently in the status of Bill Introduced since March 1, 2023. Bill HR 1305 was introduced during Congress 118 and was introduced to the House on March 1, 2023. Bill HR 1305's most recent activity was Referred to the House Committee on Foreign Affairs. as of March 1, 2023

Bipartisan Support of Bill HR 1305

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill HR 1305

Primary Policy Focus

International Affairs

Alternate Title(s) of Bill HR 1305

SUPER BUGS Act of 2023

Saving Us from Pandemic Era Resistance by Building a Unified Global Strategy Act of 2023

To direct the Secretary of Health and Human Services, in consultation with the Secretary of State, to formulate a strategy for the Federal Government to secure support from foreign countries, multilateral organizations, and other appropriate entities to facilitate the development and commercialization of qualified pandemic or epidemic products, and for other purposes.